PL2085388T3 - Nowa pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki podstawioną grupę fenyloamino-niższą alkilową oraz wprowadzoną przez ester grupę fenylową - Google Patents

Nowa pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki podstawioną grupę fenyloamino-niższą alkilową oraz wprowadzoną przez ester grupę fenylową

Info

Publication number: PL2085388T3
Authority: PL; Poland
Prior art keywords: substituents; ester; novel; lower alkyl; alkyl group
Prior art date: 2006-11-14

Application number

PL07831812T

Other languages

English (en)

Inventor

Mamoru Matsuda

Masato Nagatsuka

Toshiyuki Mori

Sachiko Kobayashi

Masatomo Kato

Miwa Takai

Original Assignee

Santen Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-14

Filing date

2007-11-14

Publication date

2013-01-31

2007-11-14 Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd

2013-01-31 Publication of PL2085388T3 publication Critical patent/PL2085388T3/pl

Links

IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical class C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 title 1
125000005907 alkyl ester group Chemical group 0.000 title 1
125000000217 alkyl group Chemical group 0.000 title 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 title 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
125000001424 substituent group Chemical group 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Vascular Medicine (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)

PL07831812T 2006-11-14 2007-11-14 Nowa pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki podstawioną grupę fenyloamino-niższą alkilową oraz wprowadzoną przez ester grupę fenylową PL2085388T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2006307651		2006-11-14
EP07831812A EP2085388B1 (en)	2006-11-14	2007-11-14	Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
PCT/JP2007/072082 WO2008059866A1 (en)	2006-11-14	2007-11-14	Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents

Publications (1)

Publication Number	Publication Date
PL2085388T3 true PL2085388T3 (pl)	2013-01-31

Family

ID=39401671

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL07831811T PL2085387T3 (pl)	2006-11-14	2007-11-14	Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową
PL07831812T PL2085388T3 (pl)	2006-11-14	2007-11-14	Nowa pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki podstawioną grupę fenyloamino-niższą alkilową oraz wprowadzoną przez ester grupę fenylową
PL07831813T PL2085389T3 (pl)	2006-11-14	2007-11-14	Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL07831811T PL2085387T3 (pl)	2006-11-14	2007-11-14	Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL07831813T PL2085389T3 (pl)	2006-11-14	2007-11-14	Pochodna 1,2-dihydrochinoliny, zawierająca jako podstawniki (podstawioną fenylem lub podstawioną grupą heterocykliczną) grupę karbonyloksy-niższą alkilową oraz wprowadzoną przez ester grupę fenylową

Country Status (12)

Country	Link
US (6)	US8008498B2 (pl)
EP (3)	EP2085388B1 (pl)
JP (3)	JP4969417B2 (pl)
KR (3)	KR20090086539A (pl)
CN (4)	CN104672130A (pl)
CA (3)	CA2669607A1 (pl)
ES (3)	ES2416289T3 (pl)
HK (1)	HK1208868A1 (pl)
NO (1)	NO342905B1 (pl)
PL (3)	PL2085387T3 (pl)
RU (1)	RU2485104C2 (pl)
WO (3)	WO2008059866A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1944290B1 (en) *	2005-09-14	2013-12-04	Santen Pharmaceutical Co., Ltd.	Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
SI1995242T1 (sl)	2006-03-14	2013-01-31	Santen Pharmaceutical Co., Ltd.	Nov derivat 1,2,3,4-tetrahidrokinoksalina z aktivnostjo vezanja glukokortikoidnega receptorja
PL2085387T3 (pl)	2006-11-14	2013-09-30	Ayumi Pharmaceutical Corp	Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową
CA2687948A1 (en)	2007-05-29	2008-12-04	Mamoru Matsuda	Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
KR20110010634A (ko) *	2008-05-12	2011-02-01	산텐 세이야꾸 가부시키가이샤	치환 옥시기를 가지는 2,2,4-트리메틸-6-페닐-1,2-디하이드로퀴놀린 유도체를 포함하는 글루코코르티코이드 수용체 작용제
EA018420B1 (ru) *	2008-09-12	2013-07-30	Сантен Фармасьютикал Ко., Лтд.	Агонист глюкокортикоидного рецептора, содержащий новые производные 1,2,3,4-тетрагидрохиноксалина с фенильной группой, имеющей структуру эфира сульфоновой кислоты, введенной в нее в качестве заместителя
CN102863872B (zh)	2008-09-30	2015-08-19	日立化成株式会社	涂布剂、使用该涂布剂的光半导体元件搭载用基板及光半导体装置
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8933024B2 (en)	2010-06-18	2015-01-13	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
JP5921235B2 (ja) *	2011-02-09	2016-05-24	あゆみ製薬株式会社	３−ヒドロキシ−６Ｈ−ベンゾ［ｃ］クロメン−６−オン誘導体およびその製造方法
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en)	2011-09-27	2013-04-04	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2805948A4 (en) *	2012-01-20	2015-05-27	Santen Pharmaceutical Co Ltd	INDUSTRIAL METHOD FOR PRODUCING A 1,2-DIHYDROCHINOLINE DERIVATIVE OR SALT, AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF
CN104080478A (zh)	2012-01-31	2014-10-01	参天制药株式会社	非水性液体组合物
JP2014139161A (ja) *	2012-12-20	2014-07-31	Santen Pharmaceut Co Ltd	１，２−ジヒドロキノリン合成中間体の製造方法
TW201609145A (zh)	2013-12-25	2016-03-16	參天製藥股份有限公司	注射劑及形成緩釋（ｄｅｐｏｔ）之方法
CN110944668A (zh)	2017-06-16	2020-03-31	学校法人同志社	用于治疗或预防眼部症状、障碍或疾病的包含mTOR抑制剂的药物及其应用
JPWO2018230713A1 (ja)	2017-06-16	2020-04-16	学校法人同志社	カスパーゼ阻害活性を有する化合物、これらの化合物を含む、角膜内皮の症状、障害または疾患を治療または予防するための医薬およびその応用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996019458A2 (en)	1994-12-22	1996-06-27	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US6696459B1 (en)	1994-12-22	2004-02-24	Ligand Pharmaceuticals Inc.	Steroid receptor modulator compounds and methods
US5696130A (en)	1994-12-22	1997-12-09	Ligand Pharmaceuticals Incorporated	Tricyclic steroid receptor modulator compounds and methods
US6372073B1 (en) *	1999-08-11	2002-04-16	Southpac Trust International Inc.	Process for producing holographic material
IL155163A0 (en) *	2000-10-02	2003-10-31	Janssen Pharmaceutica Nv	Metabotropic glutamate receptor antagonists
ES2246292T3 (es) *	2000-10-30	2006-02-16	Pfizer Products Inc.	Moduladores de receptor glucocorticoide.
CN101200450A (zh)	2002-04-30	2008-06-18	Ucb公司	2,6-喹啉基和2,6-萘基衍生物、用于制备它们的方法和它们作为vla-4抑制剂的用途
DE60322713D1 (de) *	2002-08-21	2008-09-18	Boehringer Ingelheim Pharma	Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
US7135575B2 (en) *	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
KR20070056060A (ko) *	2004-07-14	2007-05-31	리간드 파마슈티칼스 인코포레이티드	세포내 수용체 조절화합물 및 방법
JP4825636B2 (ja) *	2005-09-14	2011-11-30	参天製薬株式会社	グルココルチコイド受容体結合活性を有する新規１，２−ジヒドロキノリン誘導体
EP1944290B1 (en)	2005-09-14	2013-12-04	Santen Pharmaceutical Co., Ltd.	Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
PL2085387T3 (pl)	2006-11-14	2013-09-30	Ayumi Pharmaceutical Corp	Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową
JP2008255112A (ja) *	2007-03-13	2008-10-23	Santen Pharmaceut Co Ltd	２，２，４−トリメチル−６−フェニル−１，２−ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト
KR20100137435A (ko) *	2008-03-06	2010-12-30	신세스 게엠바하	페싯 인터피어런스 스크류
KR20110010634A (ko) *	2008-05-12	2011-02-01	산텐 세이야꾸 가부시키가이샤	치환 옥시기를 가지는 2,2,4-트리메틸-6-페닐-1,2-디하이드로퀴놀린 유도체를 포함하는 글루코코르티코이드 수용체 작용제

2007
- 2007-11-14 PL PL07831811T patent/PL2085387T3/pl unknown
- 2007-11-14 EP EP07831812A patent/EP2085388B1/en not_active Not-in-force
- 2007-11-14 WO PCT/JP2007/072082 patent/WO2008059866A1/ja not_active Ceased
- 2007-11-14 JP JP2007295256A patent/JP4969417B2/ja not_active Expired - Fee Related
- 2007-11-14 PL PL07831812T patent/PL2085388T3/pl unknown
- 2007-11-14 ES ES07831811T patent/ES2416289T3/es active Active
- 2007-11-14 JP JP2007295227A patent/JP4817020B2/ja not_active Expired - Fee Related
- 2007-11-14 US US12/312,396 patent/US8008498B2/en not_active Expired - Fee Related
- 2007-11-14 KR KR1020097009351A patent/KR20090086539A/ko not_active Ceased
- 2007-11-14 KR KR1020097009349A patent/KR101475534B1/ko not_active Expired - Fee Related
- 2007-11-14 ES ES07831813T patent/ES2391910T3/es active Active
- 2007-11-14 CA CA002669607A patent/CA2669607A1/en not_active Abandoned
- 2007-11-14 PL PL07831813T patent/PL2085389T3/pl unknown
- 2007-11-14 EP EP07831813A patent/EP2085389B1/en not_active Not-in-force
- 2007-11-14 CA CA002668596A patent/CA2668596A1/en not_active Abandoned
- 2007-11-14 RU RU2009122375/04A patent/RU2485104C2/ru active
- 2007-11-14 ES ES07831812T patent/ES2391865T3/es active Active
- 2007-11-14 WO PCT/JP2007/072083 patent/WO2008059867A1/ja not_active Ceased
- 2007-11-14 US US12/312,392 patent/US8008496B2/en active Active
- 2007-11-14 WO PCT/JP2007/072081 patent/WO2008059865A1/ja not_active Ceased
- 2007-11-14 CN CN201510012203.7A patent/CN104672130A/zh active Pending
- 2007-11-14 KR KR1020097009350A patent/KR20090086070A/ko not_active Ceased
- 2007-11-14 CA CA2668592A patent/CA2668592C/en active Active
- 2007-11-14 CN CNA2007800421193A patent/CN101605762A/zh active Pending
- 2007-11-14 US US12/312,393 patent/US8008497B2/en not_active Expired - Fee Related
- 2007-11-14 CN CNA2007800420839A patent/CN101535267A/zh active Pending
- 2007-11-14 CN CNA2007800420010A patent/CN101535266A/zh active Pending
- 2007-11-14 EP EP07831811.0A patent/EP2085387B1/en active Active
- 2007-11-14 JP JP2007295239A patent/JP4898635B2/ja not_active Expired - Fee Related
2009
- 2009-05-28 NO NO20092104A patent/NO342905B1/no unknown
2011
- 2011-06-30 US US13/135,256 patent/US8563551B2/en not_active Expired - Fee Related
- 2011-07-14 US US13/135,790 patent/US8440660B2/en not_active Expired - Fee Related
- 2011-07-14 US US13/135,765 patent/US8580784B2/en not_active Expired - Fee Related
2015
- 2015-09-30 HK HK15109650.5A patent/HK1208868A1/xx unknown

Also Published As

Publication number	Publication date
JP4898635B2 (ja)	2012-03-21
US8008497B2 (en)	2011-08-30
PL2085389T3 (pl)	2013-02-28
EP2085388B1 (en)	2012-09-05
US20110275620A1 (en)	2011-11-10
CA2668596A1 (en)	2008-05-22
US8563551B2 (en)	2013-10-22
NO20092104L (no)	2009-05-28
HK1208868A1 (en)	2016-03-18
EP2085387B1 (en)	2013-04-10
ES2391865T3 (es)	2012-11-30
US20090298826A1 (en)	2009-12-03
ES2416289T3 (es)	2013-07-31
JP4969417B2 (ja)	2012-07-04
ES2391910T3 (es)	2012-12-03
US8580784B2 (en)	2013-11-12
CA2668592A1 (en)	2008-05-22
RU2009122375A (ru)	2010-12-20
US8440660B2 (en)	2013-05-14
US20090298827A1 (en)	2009-12-03
EP2085387A1 (en)	2009-08-05
RU2485104C2 (ru)	2013-06-20
WO2008059867A1 (en)	2008-05-22
US20110275632A1 (en)	2011-11-10
CN104672130A (zh)	2015-06-03
US8008496B2 (en)	2011-08-30
EP2085389A1 (en)	2009-08-05
EP2085388A1 (en)	2009-08-05
EP2085387A4 (en)	2010-12-15
US20100056504A1 (en)	2010-03-04
CA2669607A1 (en)	2008-05-22
KR101475534B1 (ko)	2014-12-22
JP2008143889A (ja)	2008-06-26
PL2085387T3 (pl)	2013-09-30
KR20090086539A (ko)	2009-08-13
JP4817020B2 (ja)	2011-11-16
KR20090086069A (ko)	2009-08-10
WO2008059866A1 (en)	2008-05-22
CN101535267A (zh)	2009-09-16
CN101605762A (zh)	2009-12-16
EP2085389A4 (en)	2010-12-15
JP2008143891A (ja)	2008-06-26
US8008498B2 (en)	2011-08-30
KR20090086070A (ko)	2009-08-10
NO342905B1 (no)	2018-08-27
EP2085388A4 (en)	2010-12-15
US20110263600A1 (en)	2011-10-27
CA2668592C (en)	2016-04-19
EP2085389B1 (en)	2012-09-26
CN101535266A (zh)	2009-09-16
JP2008143890A (ja)	2008-06-26
WO2008059865A1 (en)	2008-05-22

Publication	Publication Date	Title
EP2085388A4 (en)	2010-12-15	NEW 1,2-DIHYDROCHINOLINE DERIVATIVE WITH SUBSTITUTED PHENYLAMINOENE ALKYL GROUP AND PHENYL GROUP INTRODUCED BY AN ESTER AS SUBSTITUENTS
ZA200710172B (en)	2008-11-26	Cyclic amine derivative having substituted alkyl group
ZA200804762B (en)	2009-04-29	1,3-oxazolidin-2-one derivatives useful as CETP inhibitors
IL189141A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
IL189142A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
TWI369353B (en)	2012-08-01	Novel compound having 4-pyridylalkylthio group as substituent
IL200102A0 (en)	2010-04-15	6-benzyl-3,3 dimethyl-2,3,4,7-tetrahydro-indolo{2,3-c} quinoline compounds, compositions containing the same and uses thereof
PL1901743T3 (pl)	2014-05-30	Pochodne chinoliny jako środki antybakteryjne
AP2008004444A0 (en)	2008-04-30	New anti-malaria derivatives of 4-aminoquinoline
EP2119702A4 (en)	2010-12-08	amide derivative
IL188395A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
ZA201002213B (en)	2011-06-29	"6-pyrimidinyl-pyrimid-4-one derivative"
ZA200801106B (en)	2009-09-30	Quinoline derivatives as antibacterial agents
IL188393A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
IL188394A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
ZA200707529B (en)	2008-09-25	Pro-fragrance and pro-flavorant compositions
ZA200704309B (en)	2009-08-26	Benzene compound having 2 or more substituents
IL178734A0 (en)	2007-02-11	Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
ZA200609067B (en)	2008-08-27	Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
GB0508820D0 (en)	2005-06-08	Lubricating compositions
ZA200609519B (en)	2008-02-27	Benzylidene-ß-Dicarbonyl compounds as novel UV-absorbers
PL375805A1 (pl)	2006-12-27	Pochodne chinoliny wykazujące aktywność jako fungicydy oraz ich stosowanie
GB0514423D0 (en)	2005-08-17	Novel compositions and compounds
ZA200710698B (en)	2009-03-25	Quinoline derivatives as antibacterial agents
GB0616498D0 (en)	2006-09-27	Novel compounds